FOSTER CITY (CBS / AP) – The Food and Drug Administration has approved Descovy, a combination HIV drug developed by biologic drugmaker Gilead Sciences.
The daily pill includes two already-approved drugs for treating the virus. The combination is the backbone of Gilead’s newest HIV medicines, and it’s part of Gilead’s HIV pill Genvoya, approved in 2015.READ MORE: Despite Fines, Pleasant Hill In-N-Out Remains Defiant Over Customer Vaccine Verifications
Gilead, of Foster City, California, is a top maker of HIV and hepatitis treatments.
Descovy carries FDA’s strictest warnings about dangerous side effects, including potentially fatal buildup of lactic acid in the blood and worsening of hepatitis B, immune system problems and kidney damage.READ MORE: Mariposa Sheriff To Announce What Killed Family On Hike In Sierra National Forest
It’s approved for treating patients aged 12 and older with the HIV-1 subtype.
Gilead says Descovy is as effective as its blockbuster Viread at a much-lower dose. It hasn’t disclosed the price.MORE NEWS: UPDATE: Judge Denies Bail for Los Gatos Mom Accused of Hosting Drunken Teen Sex Parties
© Copyright 2016 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.